1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell & Gene Therapy Cold Chain Logistics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others)
5.2.2. By Services Offered (Transportation, Storage, Packaging)
5.2.3. By Mode of Transportation (Air, Ground, Water)
5.2.4. By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others)
5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. North America Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Services Offered
6.2.3. By Mode of Transportation
6.2.4. By Holding Temperature Range
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Services Offered
6.3.1.2.3. By Mode of Transportation
6.3.1.2.4. By Holding Temperature Range
6.3.1.2.5. By End User
6.3.2. Canada Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Services Offered
6.3.2.2.3. By Mode of Transportation
6.3.2.2.4. By Holding Temperature Range
6.3.2.2.5. By End User
6.3.3. Mexico Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Services Offered
6.3.3.2.3. By Mode of Transportation
6.3.3.2.4. By Holding Temperature Range
6.3.3.2.5. By End User
7. Europe Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Services Offered
7.2.3. By Mode of Transportation
7.2.4. By Holding Temperature Range
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Services Offered
7.3.1.2.3. By Mode of Transportation
7.3.1.2.4. By Holding Temperature Range
7.3.1.2.5. By End User
7.3.2. France Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Services Offered
7.3.2.2.3. By Mode of Transportation
7.3.2.2.4. By Holding Temperature Range
7.3.2.2.5. By End User
7.3.3. United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Services Offered
7.3.3.2.3. By Mode of Transportation
7.3.3.2.4. By Holding Temperature Range
7.3.3.2.5. By End User
7.3.4. Italy Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Services Offered
7.3.4.2.3. By Mode of Transportation
7.3.4.2.4. By Holding Temperature Range
7.3.4.2.5. By End User
7.3.5. Spain Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Services Offered
7.3.5.2.3. By Mode of Transportation
7.3.5.2.4. By Holding Temperature Range
7.3.5.2.5. By End User
8. Asia Pacific Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Services Offered
8.2.3. By Mode of Transportation
8.2.4. By Holding Temperature Range
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Services Offered
8.3.1.2.3. By Mode of Transportation
8.3.1.2.4. By Holding Temperature Range
8.3.1.2.5. By End User
8.3.2. India Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Services Offered
8.3.2.2.3. By Mode of Transportation
8.3.2.2.4. By Holding Temperature Range
8.3.2.2.5. By End User
8.3.3. Japan Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Services Offered
8.3.3.2.3. By Mode of Transportation
8.3.3.2.4. By Holding Temperature Range
8.3.3.2.5. By End User
8.3.4. South Korea Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Services Offered
8.3.4.2.3. By Mode of Transportation
8.3.4.2.4. By Holding Temperature Range
8.3.4.2.5. By End User
8.3.5. Australia Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Services Offered
8.3.5.2.3. By Mode of Transportation
8.3.5.2.4. By Holding Temperature Range
8.3.5.2.5. By End User
9. Middle East & Africa Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Services Offered
9.2.3. By Mode of Transportation
9.2.4. By Holding Temperature Range
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Services Offered
9.3.1.2.3. By Mode of Transportation
9.3.1.2.4. By Holding Temperature Range
9.3.1.2.5. By End User
9.3.2. UAE Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Services Offered
9.3.2.2.3. By Mode of Transportation
9.3.2.2.4. By Holding Temperature Range
9.3.2.2.5. By End User
9.3.3. South Africa Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Services Offered
9.3.3.2.3. By Mode of Transportation
9.3.3.2.4. By Holding Temperature Range
9.3.3.2.5. By End User
10. South America Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Services Offered
10.2.3. By Mode of Transportation
10.2.4. By Holding Temperature Range
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Services Offered
10.3.1.2.3. By Mode of Transportation
10.3.1.2.4. By Holding Temperature Range
10.3.1.2.5. By End User
10.3.2. Colombia Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Services Offered
10.3.2.2.3. By Mode of Transportation
10.3.2.2.4. By Holding Temperature Range
10.3.2.2.5. By End User
10.3.3. Argentina Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Services Offered
10.3.3.2.3. By Mode of Transportation
10.3.3.2.4. By Holding Temperature Range
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Cell & Gene Therapy Cold Chain Logistics Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Cencora, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. United Parcel Service, Inc.
15.3. Catalent, Inc.
15.4. BioLife Solutions, Inc.
15.5. Cryoport System LLC.
15.6. Atelerix Ltd.
15.7. Life Science Group Ltd
15.8. Yourway Biopharma Services Company
15.9. Bertelsmann SE & Co. KGaA
15.10. NMDP BioTherapies
16. Strategic Recommendations
17. About Us & Disclaimer